1.
JAMA
; 331(23): 1995-1996, 2024 06 18.
Article
in English
| MEDLINE
| ID: mdl-38767914
Subject(s)
Drug Costs , Drug Industry , United States Federal Trade Commission , Humans , Drug Industry/economics , Drug Industry/legislation & jurisprudence , Government Regulation , United States , United States Federal Trade Commission/economics , United States Federal Trade Commission/legislation & jurisprudence , United States Food and Drug Administration/economics , United States Food and Drug Administration/legislation & jurisprudence , Drug Costs/legislation & jurisprudence
2.
Cornell Law Rev
; 99(5): 1227-58, 2014 Jul.
Article
in English
| MEDLINE
| ID: mdl-25112001
Subject(s)
Antitrust Laws , Drug Approval/economics , Drug Approval/legislation & jurisprudence , Drug Costs/legislation & jurisprudence , Drug Industry/economics , Drug Industry/legislation & jurisprudence , Legislation, Drug/economics , Marketing of Health Services/economics , Marketing of Health Services/legislation & jurisprudence , Patents as Topic/legislation & jurisprudence , Drugs, Generic/economics , Economic Competition/legislation & jurisprudence , Humans , Supreme Court Decisions , United States , United States Federal Trade Commission/economics , United States Federal Trade Commission/legislation & jurisprudence
3.
Nat Biotechnol
; 31(4): 316-7, 2013 Apr.
Article
in English
| MEDLINE
| ID: mdl-23563426
Subject(s)
Drug Industry/economics , Drug Industry/legislation & jurisprudence , Legislation as Topic/economics , United States Federal Trade Commission/economics , United States Federal Trade Commission/legislation & jurisprudence , Humans , Marketing/economics , Marketing/legislation & jurisprudence , Patents as Topic , Supreme Court Decisions , United States
4.
Mod Healthc
; 40(21): 24, 2010 May 24.
Article
in English
| MEDLINE
| ID: mdl-20540212